These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37359014)

  • 1. Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy.
    Zhang Z; Yan T; Ren D; Zhou J; Liu L; Li J; Fu S; Ni T; Xu W; Yang Y; Chen T; He Y; Zhao Y; Liu J
    Front Med (Lausanne); 2023; 10():1157775. PubMed ID: 37359014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performances of disseminated intravascular coagulation scoring systems in septic shock patients.
    Helms J; Severac F; Merdji H; Clere-Jehl R; François B; Mercier E; Quenot JP; Meziani F;
    Ann Intensive Care; 2020 Jul; 10(1):92. PubMed ID: 32651674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Validation of the Two Newly Proposed Criteria for Assessing Coagulopathy in Sepsis.
    Yamakawa K; Yoshimura J; Ito T; Hayakawa M; Hamasaki T; Fujimi S
    Thromb Haemost; 2019 Feb; 119(2):203-212. PubMed ID: 30593085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Accuracy of the Different Scoring Systems for Assessing Coagulopathy in Sepsis: A Retrospective Study.
    Chen Y; Chen W; Ba F; Zheng Y; Zhou Y; Shi W; Li J; Yang Z; Mao E; Chen E; Chen Y
    Clin Appl Thromb Hemost; 2023; 29():10760296231207630. PubMed ID: 37920943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between sepsis-induced coagulopathy and sepsis-associated coagulopathy criteria in identifying sepsis-associated disseminated intravascular coagulation.
    Zhao H; Dong Y; Wang S; Shen J; Song Z; Xue M; Shao M
    World J Emerg Med; 2024; 15(3):190-196. PubMed ID: 38855376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study.
    Ding R; Wang Z; Lin Y; Liu B; Zhang Z; Ma X
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):551-558. PubMed ID: 30015646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients].
    Xu Y; Zhu R; Sun Y; Li X; Ma X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):127-132. PubMed ID: 28625259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable Outcomes of Anticoagulation With Unfractioned Heparin in Sepsis-Induced Coagulopathy: A Retrospective Analysis of MIMIC-III Database.
    Peng JC; Nie F; Li YJ; Xu QY; Xing SP; Li W; Gao Y
    Front Med (Lausanne); 2021; 8():773339. PubMed ID: 35047524
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.
    Iizuka Y; Sanui M; Sasabuchi Y; Lefor AK; Hayakawa M; Saito S; Uchino S; Yamakawa K; Kudo D; Takimoto K; Mayumi T; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
    Crit Care; 2017 Jul; 21(1):181. PubMed ID: 28701223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality.
    Iba T; Arakawa M; Di Nisio M; Gando S; Anan H; Sato K; Ueki Y; Levy JH; Thachil J
    J Intensive Care Med; 2020 Jul; 35(7):643-649. PubMed ID: 29720054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy.
    Huang JJ; Zou ZY; Zhou ZP; Liu Y; Yang ZJ; Zhang JJ; Luan YY; Yao YM; Wu M
    Front Pharmacol; 2023; 14():1173893. PubMed ID: 37256226
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study on the value of prothrombin time for predicting the severity and prognosis of septic patients].
    Bai H; Shen L; Jing L; Liu W; Sun Z; Tang N
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jul; 34(7):682-688. PubMed ID: 36100403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Sepsis-Induced Coagulopathy in Critically Ill Pediatric Patients with Septic Shock.
    Jhang WK; Park SJ
    Thromb Haemost; 2021 Apr; 121(4):457-463. PubMed ID: 33124023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy.
    Hosseini SF; Behnam-Roudsari S; Alavinia G; Emami A; Toghyani A; Moradi S; Zadeh MM; Mohseni S; Shafiee MA
    J Res Med Sci; 2021; 26():102. PubMed ID: 34899940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation.
    Iba T; Helms J; Connors JM; Levy JH
    J Intensive Care; 2023 May; 11(1):24. PubMed ID: 37221630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study.
    Kato T; Matsuura K
    Thromb J; 2018; 16():19. PubMed ID: 30158838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
    Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey.
    Iba T; Nisio MD; Levy JH; Kitamura N; Thachil J
    BMJ Open; 2017 Sep; 7(9):e017046. PubMed ID: 28963294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive value of the maximum aggregation rate of platelet for septic shock and septic shock with disseminated intravascular coagulation].
    Cui Q; Sun X; Ma N; Liu Q; Yang H; Sun R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):238-243. PubMed ID: 36916334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.